Ginkgo Bioworks Holdings EPS - Earnings per Share 2020-2023 | DNA

Ginkgo Bioworks Holdings eps - earnings per share from 2020 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Ginkgo Bioworks Holdings Annual EPS
2022 $-1.25
2021 $-1.39
2020 $-0.10
2019 $-0.10
Ginkgo Bioworks Holdings Quarterly EPS
2023-03-31 $-0.11
2022-12-31 $-0.06
2022-09-30 $-0.41
2022-06-30 $-0.41
2022-03-31 $-0.37
2021-12-31 $-1.21
2021-09-30 $-0.08
2021-06-30 $-0.04
2021-03-31 $-0.06
2020-12-31 $0.00
2020-09-30 $-0.02
2019-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.170B $0.478B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.076B 8.19
GSK (GSK) United Kingdom $70.106B 9.78
Bio-Rad Laboratories (BIO.B) United States $11.071B 29.60
QIAGEN (QGEN) Netherlands $10.491B 22.15
Arcus Biosciences (RCUS) United States $1.611B 0.00
Biohaven (BHVN) United States $1.059B 0.00
Emergent Biosolutions (EBS) United States $0.412B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.175B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00